Informatie: Dit is niet de actueelste versie van het datamodel. Een versieoverzicht vindt u links onder Versies. De actueelste versie vindt u hier.
Informatie:
Fout:
ID
18804
Beschrijving
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00180037
Link
https://clinicaltrials.gov/show/NCT00180037
Trefwoorden
Versies (2)
- 21-11-16 21-11-16 -
- 20-09-21 20-09-21 -
Geüploaded op
21 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Parkinson's Disease NCT00180037
Eligibility Parkinson's Disease NCT00180037
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00180037
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Parkinson Disease
Item
parkinson's disease according to the uk brain bank criteria
boolean
C0030567 (UMLS CUI [1])
Hoehn and Yahr grades
Item
hoehn & yahr stadium ii until iii
boolean
C0451215 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 40 to 75 years
boolean
C0001779 (UMLS CUI [1])
Unified Parkinson's Disease Rating Scale Questionnaire
Item
updrs part iii > 15 points
boolean
C3639721 (UMLS CUI [1])
Motor fluctuations | Dyskinetic syndrome
Item
no motor fluctuations or dyskinesias
boolean
C1868976 (UMLS CUI [1])
C0013384 (UMLS CUI [2])
C0013384 (UMLS CUI [2])
Parkinson Disease Stable Duration
Item
stable parkinsonian condition for 4 weeks prior to inclusion
boolean
C0030567 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Outpatients
Item
outpatients
boolean
C0029921 (UMLS CUI [1])
Levodopa Stable
Item
patients without or with stable levodopa treatment for 4 weeks prior inclusion
boolean
C0023570 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Parkinsonian Disorders Atypical | Parkinsonian Disorders Drug-induced
Item
atypical or drug-induced parkinsonian syndromes
boolean
C0242422 (UMLS CUI [1,1])
C0205182 (UMLS CUI [1,2])
C0242422 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
C0205182 (UMLS CUI [1,2])
C0242422 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
Dyskinetic syndrome | Motor fluctuations
Item
dyskinesias or motor fluctuations
boolean
C0013384 (UMLS CUI [1])
C1868976 (UMLS CUI [2])
C1868976 (UMLS CUI [2])
coenzyme Q10
Item
coenzyme q10 treatment in the past
boolean
C0056077 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Epilepsy
Item
epileptic seizures in the history
boolean
C0014544 (UMLS CUI [1])
Hypothyroidism
Item
hypothyroidism
boolean
C0020676 (UMLS CUI [1])
Medical condition Severe Interferes with Investigational New Drug
Item
severe medical conditions with interference with study drug
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0205082 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
Cholesterol Synthesis Inhibitors | Thyroid Hormones | Anti-Arrhythmia Agents | Warfarin | Metformin
Item
treatment with cse inhibitors, thyroidal hormones, antiarrhythmic drugs, warfarin, metformin
boolean
C2917205 (UMLS CUI [1])
C0040135 (UMLS CUI [2])
C0003195 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C0025598 (UMLS CUI [5])
C0040135 (UMLS CUI [2])
C0003195 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C0025598 (UMLS CUI [5])
Vitamins | Magnesium | Vitamin E | Calcium
Item
treatment or intake of vitamins, magnesium, vitamin e, calcium
boolean
C0042890 (UMLS CUI [1])
C0024467 (UMLS CUI [2])
C0042874 (UMLS CUI [3])
C0006675 (UMLS CUI [4])
C0024467 (UMLS CUI [2])
C0042874 (UMLS CUI [3])
C0006675 (UMLS CUI [4])